Open access · OA
via OpenAlex
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Ole Köhler‐Forsberg, Jesper Krogh, Ole Mors, Michael E. Benros
Current Neuropharmacology · 2016 · ▲ 531 citations
Abstract
Accumulating evidence supports an association between depression and inflammatory processes, a connection that seems to be bidirectional. Clinical trials have indicated antidepressant treatment effects for anti-inflammatory agents, both as add-on treatment and as monotherapy. In particular, nonsteroidal anti-inflammatory drugs (NSAIDs) and cytokine-inhibitors have shown antidepressant treatment effects compared to placebo, but also statins, poly-unsaturated fatty acids, pioglitazone, minocycline, modafinil, and corticosteroids may yield antidepressant treatment effects. However, the complexity of the inflammatory cascade, limited clinical evidence, and the risk for side effects stress cautiousness before clinical application. Thus, despite proof-of-concept studies of anti-inflammatory treatment effects in depression, important challenges remain to be investigated. Within this paper, we review the association between inflammation and depression together with the current evidence on use of anti-inflammatory treatment in depression. Based on this, we address the questions and challenges that seem most important and relevant to future studies, such as timing, most effective treatment lengths and identification of subgroups of patients potentially responding better to different anti-inflammatory treatment regimens.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/1570159x14666151208113700
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Köhler‐Forsberg, O., Krogh, J., Mors, O., & Benros, M.E. (2016). Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. <em>Current Neuropharmacology</em>. https://doi.org/10.2174/1570159x14666151208113700
Vancouver
Köhler‐Forsberg O, Krogh J, Mors O, Benros ME. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. Current Neuropharmacology. 2016. doi:10.2174/1570159x14666151208113700.
BibTeX
@article{ole2016Inflam,
title = {Inflammation in Depression and the Potential for Anti-Inflammatory Treatment},
author = {Ole Köhler‐Forsberg and Jesper Krogh and Ole Mors and Michael E. Benros},
journal = {Current Neuropharmacology},
year = {2016},
doi = {10.2174/1570159x14666151208113700},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical and Experimental Dermatology 2025
Citation only
Looking beyond chronological age: the importance of frailty in biologic treatment efficacy in older individuals
Biomedicines 2022
Open access · CC-BY
Frailty in Aging and the Search for the Optimal Biomarker: A Review
Mediators of Inflammation 2022
Open access · CC-BY
Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 2025
Open access · US-GOV
Impact of Inflamatory Bowel Disease Activity on Frailty in Patients Over 60 Years
Diskapi Yildirim Beyazit Education and Research Hospital 2020
Open access · US-GOV
Correlation of Clinical Frailty Scale and Modified Frailty Index in Intensive Care Patients
Frontiers in Psychiatry 2023
Open access · CC-BY